Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations

作者: Cecilia C. Low Wang , Connie N. Hess , William R. Hiatt , Allison B. Goldfine

DOI: 10.1161/CIRCULATIONAHA.116.022194

关键词:

摘要: Cardiovascular disease remains the principal cause of death and disability among patients with diabetes mellitus. Diabetes mellitus exacerbates mechanisms underlying atherosclerosis heart failure. Unfortunately, these are not adequately modulated by therapeutic strategies focusing solely on optimal glycemic control currently available drugs or approaches. In setting multifactorial risk reduction statins other lipid-lowering agents, antihypertensive therapies, antihyperglycemic treatment strategies, cardiovascular complication rates falling, yet remain higher for than those without. This review considers mechanisms, history, controversies, new pharmacological recent evidence current guidelines management in patient to support evidence-based care outside acute setting.

参考文章(502)
Kimberly A Rosendorf, Nora L Keenan, Prevalence of hypertension and controlled hypertension - United States, 2005-2008. MMWR supplements. ,vol. 60, pp. 94- ,(2011)
UK Prospective Diabetes Study Group, None, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ. ,vol. 317, pp. 703- 713 ,(1998)
Motoaki Shichiri, Hideki Kishikawa, Nakayasu Wake, Yasuo Ohkubo, Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. ,vol. 23, ,(2000)
Aaron M. From, Christopher G. Scott, Horng H. Chen, The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study. Journal of the American College of Cardiology. ,vol. 55, pp. 300- 305 ,(2010) , 10.1016/J.JACC.2009.12.003
Paul G. Shekelle, Michael W. Rich, Sally C. Morton, Col.Sid W. Atkinson, Wenli Tu, Margaret Maglione, Shannon Rhodes, Michael Barrett, Gregg C. Fonarow, Barry Greenberg, Paul A. Heidenreich, Tom Knabel, Marvin A. Konstam, Anthony Steimle, Lynne Warner Stevenson, Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: A meta-analysis of major clinical trials☆ Journal of the American College of Cardiology. ,vol. 41, pp. 1529- 1538 ,(2003) , 10.1016/S0735-1097(03)00262-6
Erik Stroes, David Colquhoun, David Sullivan, Fernando Civeira, Robert S. Rosenson, Gerald F. Watts, Eric Bruckert, Leslie Cho, Ricardo Dent, Beat Knusel, Allen Xue, Rob Scott, Scott M. Wasserman, Michael Rocco, Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance Journal of the American College of Cardiology. ,vol. 63, pp. 2541- 2548 ,(2014) , 10.1016/J.JACC.2014.03.019
Michael J. Koren, Pernille Lundqvist, Michael Bolognese, Joel M. Neutel, Maria Laura Monsalvo, Jingyuan Yang, Jae B. Kim, Rob Scott, Scott M. Wasserman, Harold Bays, Anti-PCSK9 Monotherapy for Hypercholesterolemia Journal of the American College of Cardiology. ,vol. 63, pp. 2531- 2540 ,(2014) , 10.1016/J.JACC.2014.03.018
Effects of intensive glucose lowering in type 2 diabetes The New England Journal of Medicine. ,vol. 358, pp. 2545- 2559 ,(2008) , 10.1056/NEJMOA0802743
Stephen J. Nicholls, E. Murat Tuzcu, Srinivasa Kalidindi, Kathy Wolski, Keon-W. Moon, Ilke Sipahi, Paul Schoenhagen, Steven E. Nissen, Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. Journal of the American College of Cardiology. ,vol. 52, pp. 255- 262 ,(2008) , 10.1016/J.JACC.2008.03.051